Code: | OPT20 | Acronym: | MMRRTC14 |
Keywords | |
---|---|
Classification | Keyword |
OFICIAL | Medicine |
Active? | Yes |
Responsible unit: | Departamento de Patologia e Oncologia |
Course/CS Responsible: | Integrated Master in Medicine |
Acronym | No. of Students | Study Plan | Curricular Years | Credits UCN | Credits ECTS | Contact hours | Total Time |
---|---|---|---|---|---|---|---|
MIMED | 7 | Mestrado Integrado em Medicina- Plano oficial 2013 (Reforma Curricular) | 2 | - | 1,5 | 14 | 40,5 |
1 - To consolidate the learning concerning the basic principles of cancer and to identify the key molecular oncogenic pathways of the cell.
2 - Identify the major molecular therapeutic targets in cancer and describe their importance in cancer therapeutic management.
3 - To identify the different forms of therapeutic resistance in cancer
4 - To interpret the signaling crosstalk of the major oncogenic pathways in the context of the response and therapeutic resistance.
5 - To explain the importance of the molecular biomarkers in the clinical oncology practice, especially on the stratification of the patients and on the therapeutic decision.
6 - To discuss the importance of the translational research in cancer to the identification of new drugable targets.By the end of this Unidade Curricular Optativa, students should be able to:
1 - Undersatand the basic principles of cancer and to identify the key molecular oncogenic pathways of the cell.
2 - Identify the major molecular therapeutic targets in cancer and describe their importance in cancer therapeutic management.
3 - Identify the different forms of therapeutic resistance in cancer
4 - Interpret the signaling crosstalk of the major oncogenic pathways in the context of the response and therapeutic resistance.
5 - Explain the importance of the molecular biomarkers in the clinical oncology practice, especially on the stratification of the patients and on the therapeutic decision.
I – Brief introduction to the major signaling pathways in caner.
II – Major therapeutic targets in cancer
III – Different forms of therapy resistance: intrinsic and acquired resistance
IV – Genetic mechanism of therapeutic resistance
V – Non-genetic mechanisms of therapeutic resistance
VI – The cellular metabolism as a determinant for drug response
VII – Biomarkers as predictive factors of response or therapeutic resistance
VIII – Biomarkers as a step for personalized medicine: translational researchDesignation | Weight (%) |
---|---|
Exame | 100,00 |
Total: | 100,00 |